Skip to main content
David Cachia, MD, Neurology, Worcester, MA

DavidCachiaMD

Neurology Worcester, MA

Neurophysiology, Neurooncology

Neuro oncologist at the University of Massachusetts

Dr. Cachia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Cachia's full profile

Already have an account?

  • Office

    55 Lake Ave N
    Worcester, MA 01655
    Phone+1 508-334-3550
    Fax+1 774-442-9130

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 2013 - 2015
  • UMass Chan Medical School
    UMass Chan Medical SchoolFellowship, Clinical Neurophysiology, 2012 - 2013
  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Neurology, 2009 - 2012
  • UMass Chan Medical School
    UMass Chan Medical SchoolInternship, Internal Medicine, 2008 - 2009
  • University of Malta School of Medicine
    University of Malta School of MedicineClass of 2001

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2011 - 2025
  • SC State Medical License
    SC State Medical License 2015 - 2023
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Alpha Omega Alpha Medical Honor Society 2012
  • Clinical Scholars Award MUSC (Medical University of South Carolina) Cancer Center, 2017
  • Faculty Excellence Educator of the Block Award (2) MUSC (Medical University of South Carolina), 2016
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma  
    Mandel JJ, Yust-Katz S, Patel A, Cachia D, Liu D, Park M, Yuan Y, Kent K, de Groot JF, Neuro Oncol, 1/10/2018
  • Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients  
    Cachia D, Elshafeey NA, Kamiya-Matsuoka C, Hatami M, Alfaro-Munoz KD, Mandel JJ, Colen R, DeGroot JF, J Neurooncol, 1/1/2017
  • Dorsal Column Myelopathy after Intrathecal Chemotherapy for Leukemia  
    Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Oh..., Am J Hematol, 1/1/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Overcoming Radiation Resistance in Meningioma: The Emerging Role of CDK4/6 Inhibitor.
    Cachia D, Society of Neuro-Oncology Meeting, New Orleans, LA, 1/1/2018
  • C18-Ceramide Analogue Drug Overcomes Resistance to Temozolomide in Gliobastoma.
    Cachia D, Society of Neuro-Oncology Meeting, New Orleans, LA, 1/1/2018
  • Galectin-1 upregulates CXCR4 in glioblastoma through upregulation of CXCR4 via NF-KappaB activation.
    Cachia D, American Association for Cancer Research, 1/1/2018
  • Join now to see all

Lectures

  • Treatment of Diffuse Gliomas in Adults: What's New? 
    1/1/2018
  • Anti-Tumor Activity of CDK 4/6 Inhibitor Palbociclib in Rb+ Meningioma: Pre-clinical Assessment. 
    1/1/2016
  • RIP3 is a Critical Regulator of Radiation Induced Programmed Necrosis and Inflammation in a Preclinical Model of Glioblastoma. 
    1/1/2016
  • Join now to see all

Press Mentions

  • MUSC Studying How COVID-19 Impacts Those with Cancer
    MUSC Studying How COVID-19 Impacts Those with CancerFebruary 25th, 2021
  • Study Seeks to Better Understand How COVID-19 and Cancer Intersect
    Study Seeks to Better Understand How COVID-19 and Cancer IntersectFebruary 8th, 2021
  • MUSC Using Virus to Fight Brain Cancer
    MUSC Using Virus to Fight Brain CancerOctober 11th, 2016